Awarded without open competition
Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.
Key facts
- Buyer
- The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") · Body governed by public law
- Value
- £21,368,876 across 4 lots
- Procedure
- Award procedure without prior publication of a call for competition
- Sector
- Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
- Region
- Scotland
- Official notice
- 007093-2025 on Find a Tender
- Timeline
-
- Contract date24 Feb 2025
- Published24 Feb 2025Published the same day
Description
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses, Atezolizumab Cetuximab Doxorubicin Epirubicin Infliximab (Inflectra®), (Remicade®), (Remsima®) Nivolumab Pembrolizumab Pertuzumab The Authority intends to awarded all presentations within this Lot to a single supplier.
Lots in this award
| Lot | Supplier | Value |
|---|---|---|
| Compounded Aseptic Medicines | Baxter Healthcare Ltd | £13.7m |
| Compounded Aseptic Medicines | Qualasept Limited t/a Bath ASU | £1.57m |
| Compounded Aseptic Medicines | Baxter Healthcare Ltd | £1.06m |
| Compounded Aseptic Medicines: Compounded Aseptic Medicines - All Other Presentations | Baxter Healthcare Ltd, ITH Pharma, Qualasept Limited t/a Bath ASU | £5.09m |
About the suppliers
Baxter Healthcare Ltd: every public contract they have won, plus their Companies House record (company 00461365).
Qualasept Limited t/a Bath ASU: every public contract they have won.
ITH Pharma: every public contract they have won.